디지털 병리 워크플로우 소프트웨어 시장(2026-2030년)

The global digital pathology workflow software market is forecasted to grow by USD 167.7 mn during 2025-2030, accelerating at a CAGR of 14.1% during the forecast period. The report on the global digital pathology workflow software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements and integration of ai, rising burden of chronic diseases and critical scarcity of pathological expertise, expansion of telepathology networks and multi-institutional collaboration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global digital pathology workflow software market is segmented as below:

By Deployment

• Cloud based
• On premises

By Application

• Disease diagnosis
• Drug discovery and development
• Academic research and training
• Others

By End-User

• Hospitals and reference laboratories
• Clinical laboratories
• Pharmaceutical companies
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• Rest of World (ROW)

This study identifies the migration toward cloud-native architectures and software as service delivery models as one of the prime reasons driving the global digital pathology workflow software market growth during the next few years. Also, integration of multimodal data and emergence of integrative diagnostics and shift toward open ecosystems and company-neutral software architectures will lead to sizable demand in the market.

The report on the global digital pathology workflow software market covers the following areas:

• Global digital pathology workflow software market sizing
• Global digital pathology workflow software market forecast
• Global digital pathology workflow software market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global digital pathology workflow software market vendors that include 3DHISTECH Ltd., Aiforia Technologies PLC, Corista, Dedalus Group, F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., Gestalt Diagnostics, Hamamatsu Photonics KK, Huron Digital Pathology, Ibex Medical Analytics, Indica Labs LLC., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, Mikroscan Technologies Inc., Paige AI Inc., PathAI Inc., Proscia Inc., Sectra AB, Tribun Health, Visiopharm AS. Also, the global digital pathology workflow software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Deployment
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Digital Pathology Workflow Software Market 2020 - 2024
  • Historic Market Size - Data Table on Global Digital Pathology Workflow Software Market 2020 - 2024 ($ million)
• 5.2 Deployment segment analysis 2020 - 2024
  • Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Digital Pathology Workflow Software Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Deployment

• 8.1 Market segments
• 8.2 Comparison by Deployment
• 8.3 Cloud based - Market size and forecast 2025-2030
• 8.4 On premises - Market size and forecast 2025-2030
• 8.5 Market opportunity by Deployment
  • Market opportunity by Deployment ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Disease diagnosis - Market size and forecast 2025-2030
• 9.4 Drug discovery and development - Market size and forecast 2025-2030
• 9.5 Academic research and training - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals and reference laboratories - Market size and forecast 2025-2030
• 10.4 Clinical laboratories - Market size and forecast 2025-2030
• 10.5 Pharmaceutical companies - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Colombia - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Israel - Market size and forecast 2025-2030
  • 12.7.5 Turkey - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Technological advancements and integration of AI
  • Rising burden of chronic diseases and critical scarcity of pathological expertise
  • Expansion of telepathology networks and multi-institutional collaboration
• 13.2 Market challenges
  • High initial capital expenditure and sustained infrastructure demands
  • Interoperability issues and complex integration with legacy systems
  • Regulatory compliance hurdles and data privacy security risks
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Migration toward cloud-native architectures and software as service delivery models
  • Integration of multimodal data and emergence of integrative diagnostics
  • Shift toward open ecosystems and company-neutral software architectures

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Aiforia Technologies PLC
  • Aiforia Technologies PLC - Overview
  • Aiforia Technologies PLC - Product / Service
  • Aiforia Technologies PLC - Key offerings
  • SWOT
• 15.5 Corista
  • Corista - Overview
  • Corista - Product / Service
  • Corista - Key offerings
  • SWOT
• 15.6 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.7 FUJIFILM Holdings Corp.
  • FUJIFILM Holdings Corp. - Overview
  • FUJIFILM Holdings Corp. - Business segments
  • FUJIFILM Holdings Corp. - Key news
  • FUJIFILM Holdings Corp. - Key offerings
  • FUJIFILM Holdings Corp. - Segment focus
  • SWOT
• 15.8 Gestalt Diagnostics
  • Gestalt Diagnostics - Overview
  • Gestalt Diagnostics - Product / Service
  • Gestalt Diagnostics - Key offerings
  • SWOT
• 15.9 Ibex Medical Analytics
  • Ibex Medical Analytics - Overview
  • Ibex Medical Analytics - Product / Service
  • Ibex Medical Analytics - Key offerings
  • SWOT
• 15.10 Indica Labs LLC.
  • Indica Labs LLC. - Overview
  • Indica Labs LLC. - Product / Service
  • Indica Labs LLC. - Key offerings
  • SWOT
• 15.11 Koninklijke Philips N.V.
  • Koninklijke Philips N.V. - Overview
  • Koninklijke Philips N.V. - Business segments
  • Koninklijke Philips N.V. - Key news
  • Koninklijke Philips N.V. - Key offerings
  • Koninklijke Philips N.V. - Segment focus
  • SWOT
• 15.12 Leica Biosystems Nussloch GmbH
  • Leica Biosystems Nussloch GmbH - Overview
  • Leica Biosystems Nussloch GmbH - Product / Service
  • Leica Biosystems Nussloch GmbH - Key offerings
  • SWOT
• 15.13 Paige AI Inc.
  • Paige AI Inc. - Overview
  • Paige AI Inc. - Product / Service
  • Paige AI Inc. - Key offerings
  • SWOT
• 15.14 PathAI Inc.
  • PathAI Inc. - Overview
  • PathAI Inc. - Product / Service
  • PathAI Inc. - Key offerings
  • SWOT
• 15.15 Proscia Inc.
  • Proscia Inc. - Overview
  • Proscia Inc. - Product / Service
  • Proscia Inc. - Key offerings
  • SWOT
• 15.16 Sectra AB
  • Sectra AB - Overview
  • Sectra AB - Business segments
  • Sectra AB - Key offerings
  • Sectra AB - Segment focus
  • SWOT
• 15.17 Tribun Health
  • Tribun Health - Overview
  • Tribun Health - Product / Service
  • Tribun Health - Key offerings
  • SWOT
• 15.18 Visiopharm AS
  • Visiopharm AS - Overview
  • Visiopharm AS - Product / Service
  • Visiopharm AS - Key news
  • Visiopharm AS - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations